My watch list
my.bionity.com  
Login  

Short description

The San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET) was created in 1995 as a joint-venture between the San Raffaele Scientific Institute and the Telethon Foundation for the implementation of basic and clinical research for genetic diseases. The mission of the Institute is to perform cutting edge science in the field of gene and cellular therapy and to promote the translation of basic discoveries into therapeutic advances.

Watchlist

This is where you can add this research institute to your personal favourites

Additional Information

More about San Raffaele Telethon Institute for Gene Therapy
Contact
San Raffaele Telethon Institute for Gene Therapy


Italy
  • News

    Gene therapy breakthrough heralds treatment for beta-thalassemia

    Italian scientists pioneering a new gene transfer treatment for the blood disorder beta-thalassemia have successfully completed preclinical trials, claiming they can correct the lack of beta-globin in patients' blood cells which causes the disease. The research, published in EMBO Molecular ... more

    AMT Makes Advance in the Development of its Gene Therapy for Hemophilia B

    Amsterdam Molecular Therapeutics announced that it obtained a license from 'TIGET' San Raffaele Telethon Institute For Gene Therapy, Italy, to use their micro-RNA technology to prevent immune responses against gene therapy for Hemophilia B. This technology enables AMT to accelerate the deve ... more

  • Research Institutes

    San Raffaele Telethon Institute for Gene Therapy

    The San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET) was created in 1995 as a joint-venture between the San Raffaele Scientific Institute and the Telethon Foundation for the implementation of basic and clinical research for genetic diseases. The mission of the Institute is to pe ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE